CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

Sino and AstraZeneca sign licence agreement for TQC3721

PartnershipTQC3721Positive
AI Analysis

Summary

AstraZeneca and Sino Biopharmaceutical's subsidiary CTTQ have signed an exclusive licence agreement for TQC3721.

Importance:5/10
Sentiment:
0.30
licensing agreementexclusive licencepartnership
Related Companies

Read the original article

Published by Pharmaceutical Technology on July 9, 2026 9:48 AM

Read Original